Last update 19 Sep 2024
Sinphar Pharmaceutical Co. Ltd.

Sinphar Pharmaceutical Co. Ltd.

Public Company|
1977|
Taiwan Province, China
|
500-1,000
| TPE: 1734|

Overview

Tags

Neoplasms
Nervous System Diseases
Otorhinolaryngologic Diseases
Small molecule drug
Herbal medicine

Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Top 5 Drug TypeCount
Small molecule drug4
Herbal medicine1
Unknown1
Top 5 TargetCount
Tubulin2

Corporation Tree

Boost your research with our corporation tree data.
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 05 Oct 2024

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Discovery
1
1
Preclinical
Phase 2 Clinical
1
2
Phase 3 Clinical
Other
3
Login to view more data

Current Projects

Drug(Targets)IndicationsGlobal Highest Phase
SB04
dry age-related macular degeneration
More
Phase 3 Clinical
Paclitaxel
( Tubulin )
Triple Negative Breast Cancer
More
Phase 3
SCB-01A
( Tubulin )
Head and Neck Neoplasms
More
Phase 2
GF159
Brain Diseases
More
Clinical
SB02
Neoplasms
More
Preclinical
Login to view more data

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
Unearth financing trends to validate and advance investment opportunities.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free